Literature DB >> 8660985

Genomic Organization of the ATM gene.

T Uziel1, K Savitsky, M Platzer, Y Ziv, T Helbitz, M Nehls, T Boehm, A Rosenthal, Y Shiloh, G Rotman.   

Abstract

The ATM gene was recently identified and found to be responsible for the genetic disorder ataxiatelgiectasia. The major ATM transcript is 13 kb. Using long-distance PCR, we determined the genomic structure of this gene and identified all of its exon-intron boundaries. The ATM gene spans approximately 150 kb of genomic DNA and consists of 66 exons. The initiation codon falls within exon 4. The last exon is 3.8 kb and contains the stop codon and a 3'-untranslated region of about 3600 nucleotides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660985     DOI: 10.1006/geno.1996.0201

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  36 in total

1.  Global analysis of ATM polymorphism reveals significant functional constraint.

Authors:  Y R Thorstenson; P Shen; V G Tusher; T L Wayne; R W Davis; G Chu; P J Oefner
Journal:  Am J Hum Genet       Date:  2001-07-03       Impact factor: 11.025

2.  Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.

Authors:  N Zhang; P Chen; K K Khanna; S Scott; M Gatei; S Kozlov; D Watters; K Spring; T Yen; M F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  The controlling role of ATM in homologous recombinational repair of DNA damage.

Authors:  C Morrison; E Sonoda; N Takao; A Shinohara; K Yamamoto; S Takeda
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

4.  Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.

Authors:  Jana Soukupova; Petr Pohlreich; Eva Seemanova
Journal:  Neuromolecular Med       Date:  2011-08-11       Impact factor: 3.843

5.  Mantle cell lymphoma is characterized by inactivation of the ATM gene.

Authors:  C Schaffner; I Idler; S Stilgenbauer; H Döhner; P Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 6.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

7.  Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis.

Authors:  Chen Mao; Vincent C H Chung; Ben-Fu He; Rong-Cheng Luo; Jin-Ling Tang
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

8.  ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.

Authors:  T Stankovic; A M Kidd; A Sutcliffe; G M McGuire; P Robinson; P Weber; T Bedenham; A R Bradwell; D F Easton; G G Lennox; N Haites; P J Byrd; A M Taylor
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 9.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

10.  p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.

Authors:  Andrea Prodosmo; Andrea De Amicis; Cecilia Nisticò; Mario Gabriele; Giuliana Di Rocco; Laura Monteonofrio; Maria Piane; Enrico Cundari; Luciana Chessa; Silvia Soddu
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.